Epilepsy and pregnancy: An obstetric perspective

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 2, 2004, Pages 371-379

  Richmond, Jane R ^a   Krishnamoorthy, Preetha ^b   Andermann, Eva ^c   Benjamin, Alice ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Congenital malformation; Epilepsy; Neonatal outcome; Obstetric outcome; Pregnancy

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; ANENCEPHALUS; CARDIOMYOPATHY; CARDIOVASCULAR MALFORMATION; CENTRAL NERVOUS SYSTEM MALFORMATION; CHROMOSOME DISORDER; CLEFT LIP; CLEFT PALATE; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONTINGENCY TABLE; CONTROLLED STUDY; DIGESTIVE SYSTEM MALFORMATION; EPILEPSY; FEMALE; FETUS; FETUS DEATH; FETUS DISEASE; GENITAL MALFORMATION; HERNIA; HUMAN; HYPERTENSION; HYPOSPADIAS; INSTRUMENTAL DELIVERY; KIDNEY MALFORMATION; LABOR INDUCTION; MAJOR CLINICAL STUDY; MICROCEPHALY; MUSCULOSKELETAL SYSTEM MALFORMATION; NEURAL TUBE DEFECT; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; REVIEW; STILLBIRTH; TREATMENT OUTCOME; URINARY TRACT MALFORMATION;

EID: 1342302925     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2003.09.020     Document Type: Article

References (27)

1. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 1996;71:576-86.
2. American Academy of Neurology Quality Standards Subcommittee. Practice parameter: management issues for women with epilepsy [summary statement]. Neurology 1998;51:944-8.
3. Bjerkedal T, Bahne S. The course and outcome of pregnancy in women with epilepsy. Acta Obstet Gynec Scand 1973;52:245-8.
4. Yerby M, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia 1985;26: 631-5.
5. Egenaes J. Outcome of pregnancy in women with epilepsy, Norway 1967 to 1978: complications during pregnancy and delivery. In: Janz D, Bossi L, Dam M, Helge H, Richens A, Schmidt D, editors. Epilepsy, pregnancy, and the child. New York: Raven Press; 1982, p. 81-5.
6. Nelson KB, Ellenberg JH. Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children. Neurology 1982;32:1247-54.
7. Andermann E, Dansky L, Kinch RA. Complications of pregnancy, labour and delivery in epileptic women. In: Janz D, Bossi L, Dam M, Helge H, Richens A, Schmidt D, editors. Epilepsy, pregnancy, and the child. New York: Raven Press; 1982. p. 61-74.
8. Bjerkedal T. Outcome of pregnancy in women with epilepsy, Norway 1967-1978: gestational age, birth weight and survival of the newborn. In: Janz D, Bossi L, Dam M, Helge H, Richens A, Schmidt D, editors. Epilepsy, pregnancy, and the child. New York: Raven Press; 1982. p. 175-8.
9. Hiilesmaa VK, Teramo K, Granström ML, Bardy AH. Fetal head growth retardation associated with maternal antiepileptic drugs. Lancet 1981;2:165-7.
10. Hiilesmaa VK, Bardy A, Teramo K. Obstetric outcome in women with epilepsy. Am J Obstet Gynecol 1985;152:499-504.
11. Tanganelli P, Regesta G. Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study. Neurology 1992;42:89-93.
12. Duncan S, Mercho S, Lopes-Cendes I, Seni MH, Benjamin A, Dubeau F, et al. Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality. Epilepsia 2001;42:750-3.
13. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin study. Lancet 1991;338:131-7.
14. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
15. Van Allen MI, Fraser FC, Dallaire L, Allanson J, McLeod DR, Andermann E, et al. Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. CMAJ 1993;149:1239-43.
16. Dansky LV, Rosenblatt DS, Andermann E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology 1992; 42:32-42.
17. Dansky LV, Andermann E, Rosenblatt D, Sherwin AL, Andermann F. Anticonvulsants, folate levels, and pregnancy outcomes: a prospective study. Ann Neurol 1987;21:176-82.
18. Hiilesmaa VK. Pregnancy and birth in women with epilepsy. Neurology 1992;42:8-11.
19. Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992;42:149-60.
20. Commission on Genetics, Pregnancy, and the Child; International League against Epilepsy. Guidelines for the care of women of childbearing age with epilepsy. Epilepsia 1993;34:588-9.
21. Andermann E, Andermann F, Dansky L. Counseling for epileptic women of childbearing age. In: Dam M, Gram L, Penry JK, editors. Advances in epileptology: XIIth Epilepsy International Symposium. New York: Raven Press; 1981. p. 219-27.
22. Zahn CA, Morrell MJ, Collins SD, Labiner DM, Yerby MS. Management issues for women with epilepsy: a review of the literature. Neurology 1998;51:949-56.
23. Kallen B. A register of maternal epilepsy and delivery outcome with special reference to drug use. Acta Neurol Scand 1986;73: 253-9.
24. Battino D, Granata T, Binelli S, Caccamo ML, Canevini MP, Canger R, et al. Intrauterine growth in the offspring of epileptic mothers. Acta Neurol Scand 1992;86:555-7.
25. Nakane Y, Okumo T, Takahashi R, Sato Y, Wada T, Sato T, et al. Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 1980;21:663-80.
26. Kaneko S, Battino D, Andermann E, Wada K, Kan R, Takeda A, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33:145-58.
27. Lindhout D, Hoppener RJEA, Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 1984;25:77-83.